MOSCOW (Reuters) – Russia has sent Indian regulators documents to register its Sputnik-M vaccine for use in children ages 12-17, the Russian Direct Investment Fund (RDIF) said on Monday.
The Russian Ministry of Health registered Sputnik M in late November and said the shots are expected to be available by the end of December.
Keywords: